These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reduction of NANOG Mediates the Inhibitory Effect of Aspirin on Tumor Growth and Stemness in Colorectal Cancer. Wang H, Liu B, Wang J, Li J, Gong Y, Li S, Wang C, Cui B, Xue X, Yang M, Fan W, Kang Z, Kamran M, Xu J, Tian P, Luo Y, Hou Z, Dong L, Ren Y, Li M, Wen Q, Cheng W, Xu L, Wang L, Liu Q. Cell Physiol Biochem; 2017; 44(3):1051-1063. PubMed ID: 29179207 [Abstract] [Full Text] [Related]
4. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways. Wang L, Liu Y, Zhou Y, Wang J, Tu L, Sun Z, Wang X, Luo F. J Exp Clin Cancer Res; 2019 Feb 21; 38(1):93. PubMed ID: 30791957 [Abstract] [Full Text] [Related]
6. Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition. Wei F, Rong XX, Xie RY, Jia LT, Wang HY, Qin YJ, Chen L, Shen HF, Lin XL, Yang J, Yang S, Hao WC, Chen Y, Xiao SJ, Zhou HR, Lin TY, Chen YS, Sun Y, Yao KT, Xiao D. Oncotarget; 2015 Oct 27; 6(33):35023-39. PubMed ID: 26418951 [Abstract] [Full Text] [Related]
10. Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway. Yang J, Liao D, Chen C, Liu Y, Chuang TH, Xiang R, Markowitz D, Reisfeld RA, Luo Y. Stem Cells; 2013 Feb 27; 31(2):248-58. PubMed ID: 23169551 [Abstract] [Full Text] [Related]
12. Regulation of colorectal carcinoma stemness, growth, and metastasis by an miR-200c-Sox2-negative feedback loop mechanism. Lu YX, Yuan L, Xue XL, Zhou M, Liu Y, Zhang C, Li JP, Zheng L, Hong M, Li XN. Clin Cancer Res; 2014 May 15; 20(10):2631-42. PubMed ID: 24658157 [Abstract] [Full Text] [Related]
13. Preclinical analysis of the anti-tumor and anti-metastatic effects of Raf265 on colon cancer cells and CD26(+) cancer stem cells in colorectal carcinoma. Chow AK, Cheng NS, Lam CS, Ng L, Wong SK, Wan TM, Man JH, Cheung AH, Yau TC, Poon JT, Law WL, Pang RW. Mol Cancer; 2015 Apr 11; 14():80. PubMed ID: 25884645 [Abstract] [Full Text] [Related]
14. Gambogic acid inhibits growth, induces apoptosis, and overcomes drug resistance in human colorectal cancer cells. Wen C, Huang L, Chen J, Lin M, Li W, Lu B, Rutnam ZJ, Iwamoto A, Wang Z, Yang X, Liu H. Int J Oncol; 2015 Nov 11; 47(5):1663-71. PubMed ID: 26397804 [Abstract] [Full Text] [Related]
15. Gambogic acid induces apoptosis and inhibits colorectal tumor growth via mitochondrial pathways. Huang GM, Sun Y, Ge X, Wan X, Li CB. World J Gastroenterol; 2015 May 28; 21(20):6194-205. PubMed ID: 26034354 [Abstract] [Full Text] [Related]
16. α-Mangostin-encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway. Chandra Boinpelly V, Verma RK, Srivastav S, Srivastava RK, Shankar S. J Cell Mol Med; 2020 Oct 28; 24(19):11343-11354. PubMed ID: 32830433 [Abstract] [Full Text] [Related]
17. Endothelial cells activate the cancer stem cell-associated NANOGP8 pathway in colorectal cancer cells in a paracrine fashion. Wang R, Bhattacharya R, Ye X, Fan F, Boulbes DR, Xia L, Ellis LM. Mol Oncol; 2017 Aug 28; 11(8):1023-1034. PubMed ID: 28453235 [Abstract] [Full Text] [Related]
18. Lidocaine inhibits proliferation and induces apoptosis in colorectal cancer cells by upregulating mir-520a-3p and targeting EGFR. Qu X, Yang L, Shi Q, Wang X, Wang D, Wu G. Pathol Res Pract; 2018 Dec 28; 214(12):1974-1979. PubMed ID: 30262429 [Abstract] [Full Text] [Related]
19. Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin. Chan KC, Chan LS, Ip JC, Lo C, Yip TT, Ngan RK, Wong RN, Lo KW, Ng WT, Lee AW, Tsao GS, Kahn M, Lung ML, Mak NK. Sci Rep; 2015 Apr 21; 5():9979. PubMed ID: 25897700 [Abstract] [Full Text] [Related]
20. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment. Zhang Z, Qian H, Huang J, Sha H, Zhang H, Yu L, Liu B, Hua D, Qian X. Int J Nanomedicine; 2018 Apr 21; 13():4961-4975. PubMed ID: 30214200 [Abstract] [Full Text] [Related] Page: [Next] [New Search]